Stock Trend Analysis Report
Prepared for you on Wednesday, January 19, 2022.
Elevation Oncology, Inc. - Common stock (NASDAQ:ELEV)
Bull Market Weakness (+75) - ELEV is showing signs of short-term weakness, but still remains in the confines of a long-term uptrend. Keep an eye on ELEV as it may be in the beginning stages of a reversal.
Is it time to buy, sell, or avoid ELEV?
MarketClub looks at technical strength and momentum to determine if the timing is right for ELEV.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for ELEV
The long-term trend has been DOWN since Jul 21st, 2021 at 10.5800
The intermediate-term trend has been UP since Jan 3rd, 2022 at 6.1299
The short-term trend has been UP since Jan 19th, 2022 at 6.6199
Smart Scan Analysis for ELEV
Based on our trend formula, ELEV is rated as a +70 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|52wk High||16.22||52wk High Date||2021-07-12|
|52wk Low||4.15||52wk Low Date||2021-12-17|
|Average Volume||72,361||Shares Outstanding||23,226|